Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Beta Blocker (1)
- Cardiac Sodium MRI (1)
- Chronic Kidney Disease (1)
- Chronic kidney disease (1)
- Coronary artery disease (1)
-
- Dialytic Clearance (1)
- ECG Gating (1)
- End stage renal disease (1)
- End-Stage Renal diseaes (1)
- Endothelial dysfunction (1)
- Intensity Correction (1)
- Magnetic resonance imaging (1)
- Myocardial perfusion (1)
- Myocardial stunning (1)
- Peritoneal dialysis (1)
- Pharmacokinetics (1)
- Sodium-23 (1)
- Surface Coil (1)
- Tissue sodium concentration (1)
Articles 1 - 4 of 4
Full-Text Articles in Nephrology
Noninvasive Quantification Of Tissue Sodium Concentration In The Kidney Disease Spectrum Using 23na Magnetic Resonance Imaging, Fabio R. Salerno
Noninvasive Quantification Of Tissue Sodium Concentration In The Kidney Disease Spectrum Using 23na Magnetic Resonance Imaging, Fabio R. Salerno
Electronic Thesis and Dissertation Repository
Chronic kidney disease (CKD), especially when requiring kidney replacement therapy (hemodialysis (HD) and peritoneal dialysis (PD)), is associated with extracellular water expansion with increased total body sodium. Sodium can also be accumulated in tissues independently of extracellular water. Sodium-23 magnetic resonance imaging (23Na MRI) can quantify the concentration of sodium nuclei in tissues. Applied to the human leg, quantification of tissue sodium concentrations mainly at the skin and muscle level is possible. We hypothesized that increased tissue sodium concentrations exert toxic effects in CKD and dialysis. We aimed to (1) compare tissue sodium concentrations in adults, children and …
Exploration Of The Pathophysiological Mechanisms Underlying Hemodialysis Associated Cardiac Ischemic Injury, Lisa Yun Jeong Hur
Exploration Of The Pathophysiological Mechanisms Underlying Hemodialysis Associated Cardiac Ischemic Injury, Lisa Yun Jeong Hur
Electronic Thesis and Dissertation Repository
Hemodialysis (HD) provides life-saving treatment in individuals with kidney failure. However, HD is associated with poor quality of life and extremely high mortality rates mainly caused by cardiovascular disease due to heart failure and sudden cardiac death. Standard pharmacological treatment developed within the non-kidney disease community are largely ineffective in HD patients because of the difference in pathophysiology of cardiovascular mortality. HD treatment causes hypotension and recurrent ischemic injury to multiple vascular beds including the heart, leading to heart failure. These injuries can be abrogated by improving the patient’s tolerability of the treatment. To apply interventions that may improve hemodynamic …
Technical Adaptations For Cardiac Sodium Mri, Taylor L. Marcus
Technical Adaptations For Cardiac Sodium Mri, Taylor L. Marcus
Electronic Thesis and Dissertation Repository
Cardiac sodium (Na+) MRI has the potential to unveil relationships between chronic kidney disease (CKD) and cardiovascular disease (CVD). Unfortunately, this modality requires many technical adaptations before it’s possible to extract and compare image data between individuals. This study investigated whether cardiac electrocardiogram (ECG) gating could improve image quality, and whether a uniform phantom could increase signal uniformity if a surface coil is used to acquire the image. Healthy participants were imaged with a custom-built surface coil and 3.0-T MR system. Cardiac gated images presented with a decreased signal-to-noise ratio (SNR), but intensity correction significantly increased image signal …
Beta Blocker Dialyzability And Effectiveness In Chronic Hemodialysis Patients, Alvin Tieu
Beta Blocker Dialyzability And Effectiveness In Chronic Hemodialysis Patients, Alvin Tieu
Electronic Thesis and Dissertation Repository
Of the minimal information describing drug dialyzability, the majority was obtained prior to modern hemodialysis membranes. This study characterized the dialyzability of the most commonly prescribed beta blockers in patients undergoing high-flux hemodialysis. Eight subjects were recruited to a pharmacokinetic, 4-way crossover trial. Drug concentrations were measured using mass spectrometry and dialyzability determined by the arterial-venous difference and recovery clearance methods. A provincial-wide retrospective cohort study was designed to determine the effect of dialyzability on adverse clinical outcomes. Beta blocker efficacy can be hindered if substantial clearance occurs during dialysis. Our results demonstrate atenolol and metoprolol are extensively cleared during …